Tri Locum Partners LP Mereo Biopharma Group PLC Transaction History

Tri Locum Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.2 - $3.17 $2.76 Million - $3.97 Million	-1,253,729 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.94 - $4.08 $3.69 Million - $5.12 Million	1,253,729 New	1,253,729 $3.97 Million
Q1 2021 May 17, 2021	SELL	$2.6 - $4.43 $1.89 Million - $3.23 Million	-728,710 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.95 - $3.6 $1.42 Million - $2.62 Million	728,710 New	728,710 $2.61 Million

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $441M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.